The effects of the binding of substrates and inhibitors (folate, dihydrofolate, folinic acid, trimethoprim, methotrexate and aminopterin) to
Lactobacillus casei
dihydrofolate reductase on the histidine residues of the enzyme have been studied by
1
H n. m. r. spectroscopy. The more weakly binding (rapidly exchanging) inhibitors 2, 4-diaminopyrimidine and
p
-aminobenzoyl-l-glutamate, which can be regarded as ‘fragments’ of methotrexate, have also been studied as an aid in interpreting the effects of the strongly-binding ligands.
p
-Aminobenzoyl-l-glutamate binds to two sites on the enzyme; binding to the stronger site is competitive with methotrexate, and affects three histidine residues, denoted H
A
, H
E
and H
F
. The second site is 30-fold weaker, is not competitive with methotrexate, and affects a single histidine residue (either H
B
or H
C
). The binding to the first site is 25-fold stronger in the presence of 2, 4-diaminopyrimidine, while binding to the second site is unaffected. Folate, dihydrofolate and folinic acid have identical effects on the histidine residues; the p
K
of H
E
is increased from 6.54 to 6.75, and that of H
F
from 6.54 to
ca
. 7.2, while the C2-H resonance of H
A
is shifted downfield. Methotrexate and aminopterin affect the same three histidine residues as does folate; for H
A
and H
F
the effects are the same as those produced by folate, while the p
K
of H
E
is decreased from 6.54 to 6.2. Trimethoprim and 2,4-diaminopyrimidine have effects very similar to those of methotrexate, with the exception that histidine H
F
is not affected by these compounds (which lack the
p
-amino-benzoyl-l-glutamate moiety).